Oncology · Phase I

Top sponsors

• Chinese Academy of 70 programs
• First People's Hospital 62 programs
• Takeda 49 programs
• United Therapeutics Europe 41 programs
• BEONE MEDICINES AUS 40 programs
• Regeneron UK 34 programs
• Anaxis Pharma 31 programs
• Chongqing Precision Biotech 27 programs
• Janssen-Cilag International N.V 27 programs
• Novartis India 27 programs
• Boehringer Ingelheim 24 programs
• BRIGHT MINDS BIOSCIENCES 23 programs

1. AVI-4126 Injection (RESTEN-NG®)

   Sarepta Therapeutics

   Neoplasms

   phase 1 · small molecule · completed

   1 trial →

2. AVN-944 capsules for oral administration

   Vertex Pharmaceuticals (Australia) Pty.

   Acute Leukemia

   phase 1 · small molecule · completed

   1 trial →

3. AZD0530

   AstraZeneca

   Solid Tumor

   phase 1 · small molecule · completed

   1 trial →

4. AZD2014 3 on/4 off & weekly paclitaxel

   United Therapeutics Europe Ltd

   Advanced Cancer

   phase 1 · small molecule · completed

   1 trial →

5. AZD3514

   AstraZeneca

   Prostate Cancer

   phase 1 · small molecule · completed

   1 trial →

6. AZD5363+Olaparib+Durvalumab

   Hospital Authority, Hong Kong

   Solid Tumor, Adult

   phase 1 · small molecule · active

   1 trial →

7. AZD6244

   AstraZeneca

   Neoplasms,

   phase 1 · small molecule · completed

   1 trial →

8. AZD7762

   AstraZeneca

   Cancer

   phase 1 · small molecule · terminated

   1 trial →

9. AZD9150

   IONIS PHARMACEUTICALS INC

   Advanced Adult Hepatocellular Carcinoma

   phase 1 · small molecule · completed

   1 trial →

10. AdV-tk

    Candel Therapeutics

    Pancreatic Adenocarcinoma

    phase 1 · mab · completed

    1 trial →

11. Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)

    United Therapeutics Europe Ltd

    Urothelial Carcinoma

    phase 1 · mab · active

    1 trial →

12. Aflibercept (AVE0005)

    Regeneron UK Limited

    Neoplasm Malignant

    phase 1 · small molecule · completed

    2 trials →

13. Alisertib

    Takeda

    Advanced Solid Tumors

    phase 1 · small molecule · completed

    7 trials →

14. Alisertib

    Takeda

    Solid Tumors

    phase 1 · small molecule · completed

    1 trial →

15. Alisertib

    Takeda

    B-cell Follicular Lymphoma

    phase 1 · small molecule · completed

    1 trial →

16. All-trans retinoic acid

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 1 · small molecule · active

    1 trial →

17. Allogeneic anti-CD7 CAR-T cells (BEAM-201)

    Beam Therapeutics

    T-Cell Acute Lymphoblastic Leukemia/Lymphoma

    phase 1 · mab · active

    1 trial →

18. An Open-Label for Solid tumors and ovarian cancer

    Lacuna Pharma Pty Ltd

    Solid tumors and ovarian cancer

    phase 1 · other · active

    1 trial →

19. An Ophthalmic Safety Study of New Investigational Drug in Breast Cancer Patients

    AstraZeneca AB

    Breast Cancer

    phase 1 · other · active

    1 trial →

20. An open label for High grade serous ovarian cancer

    Disc Medicine

    High grade serous ovarian cancer

    phase 1 · other · active

    1 trial →

21. Anlotinib hydrochloride,Penpulimab

    The First People's Hospital of Lianyungang

    Colorectal Cancer

    phase 1 · small molecule · active

    1 trial →

22. Anti-CD123 CAR NK cells

    Chongqing Precision Biotech Co., Ltd

    AML (Acute Myeloid Leukemia)

    phase 1 · small molecule · active

    1 trial →

23. Anti-CD19 Universal CAR-T Cells injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

    phase 1 · mab · active

    1 trial →

24. Anti-CD19-CAR

    The First People's Hospital of Lianyungang

    Leukemia

    phase 1 · mab · active

    1 trial →

25. Anti-CD30 CAR T cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Adult T-Cell Lymphoma/Leukaemia

    phase 1 · gene therapy · active

    1 trial →

26. Anti-CD5 CAR NK cells

    Chongqing Precision Biotech Co., Ltd

    T-ALL/Lymphoma

    phase 1 · mab · active

    1 trial →

27. Anti-CDH17 CAR-T cells infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    CDH17-positive Advanced Solid Tumors

    phase 1 · mab · active

    1 trial →

28. Anti-CLL1 CART cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Myeloid Leukemia

    phase 1 · small molecule · active

    1 trial →

29. Anti-GD2 ADC M3554 in Advanced Solid Tumors

    Merck Sharp and Dohme

    Advanced Solid Tumors

    phase 1 · other · active

    1 trial →

30. Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

    Merck Sharp and Dohme

    Advanced Solid Tumors

    phase 1 · other · active

    1 trial →

31. Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody

    Takeda

    Metastatic Adenocarcinoma of the Colon or Rectum

    phase 1 · mab · completed

    1 trial →

32. Anti-SEMA4D Monoclonal Antibody VX15/2503

    VACCINEX, INC.

    Colon Carcinoma Metastatic in the Liver

    phase 1 · mab · completed

    1 trial →

33. Anti-SEMA4D Monoclonal Antibody VX15/2503

    VACCINEX, INC.

    Metastatic Melanoma

    phase 1 · mab · terminated

    1 trial →

34. Arm 1 cemiplimab

    Regeneron UK Limited

    Hepatocellular Carcinoma

    phase 1 · small molecule · active

    1 trial →

35. Arsenic trioxide

    Teva Pharma GmbH

    Chronic Myelogenous Leukemia

    phase 1 · small molecule · terminated

    1 trial →

36. Atezolizumab

    Hoffmann-La Roche

    Advanced Ovarian Cancer

    phase 1 · small molecule · terminated

    1 trial →

37. Atezolizumab

    Jazz Pharmaceuticals Ireland Limited

    Endometrial Cancer

    phase 1 · small molecule · active

    1 trial →

38. Atovaquone Oral Suspension

    United Therapeutics Europe Ltd

    Locally Advanced Non-Small Cell Lung Cancer

    phase 1 · small molecule · completed

    1 trial →

39. Atu027

    Silence Therapeutics plc

    Advanced Solid Tumors

    phase 1 · small molecule · completed

    1 trial →

40. Autologous Natural Killer Cell Therapy

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma

    phase 1 · small molecule · active

    1 trial →

41. Autologous tumor-infiltrating lymphocyte cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Solid Tumor

    phase 1 · mab · terminated

    1 trial →

42. Autologous γδT cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Hodgkin's Lymphoma

    phase 1 · mab · active

    1 trial →

43. Axatilimab

    Syndax Pharmaceuticals

    Solid Tumor

    phase 1 · small molecule · completed

    1 trial →

44. Azenosertib

    Zentalis Pharmaceuticals

    Osteosarcoma

    phase 1 · small molecule · completed

    1 trial →

45. Azenosertib

    Zentalis Pharmaceuticals

    Solid Tumor

    phase 1 · small molecule · active

    2 trials →

46. BAY2965501

    Bayer HealthCare AG

    Advanced Solid Tumors

    phase 1 · small molecule · active

    1 trial →

47. BBO-10203

    BridgeBio Oncology Therapeutics

    Solid Tumor, Adult

    phase 1 · small molecule · active

    1 trial →

48. BBO-11818

    BridgeBio Oncology Therapeutics

    Non-Small Cell Lung Cancer

    phase 1 · small molecule · active

    1 trial →

Frequently asked questions